Prothena Corp Public (PRTA) Capital Expenditures (2012 - 2026)
Prothena Corp Public (PRTA) recorded Capital Expenditures of $652,000 in Q2 2026, up 658.1% from $86,000 a year earlier.
Powered by 
Analysis
Prothena Corp Public (PRTA) Capital Expenditures (2012 - 2026) Analysis & Trends
On a TTM basis, Prothena Corp Public's Capital Expenditures came in at $662,000 as of Jun 30, 2026, up 267.8% year-over-year; for FY2025, it was $138,000, down 53.7% from FY2024.
- Annual Capital Expenditures has a five-year compound annual growth rate of -6.8% (FY2020 to FY2025).
- Across earlier years, Capital Expenditures came in at $298,000 in FY2024 (-89.4%), $2.81 million in FY2023 (+505.6%), $464,000 in FY2022 (-19.3%) and $575,000 in FY2021 (+193.4%).
- The Q2 2026 figure is the highest quarterly Capital Expenditures since Q4 2023.
- On a year-over-year basis, Capital Expenditures rose in two of the last six quarters, with growth averaging 62.5%.
- Peak year-over-year performance for Capital Expenditures in the last five years was growth of 925.8% in Q4 2023, against a decline of 98.0% in Q3 2024 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Prothena Corp Public | 451.21 Mn | -804.86 Mn | - | 652,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 652,000.00 |
| Sep 30, 2025 | 10,000.00 |
| Jun 30, 2025 | 86,000.00 |
| Mar 31, 2025 | 42,000.00 |
| Dec 31, 2024 | 43,000.00 |
| Sep 30, 2024 | 9,000.00 |
| Jun 30, 2024 | 143,000.00 |
| Mar 31, 2024 | 103,000.00 |
| Dec 31, 2023 | 1.55 Mn |
| Sep 30, 2023 | 442,000.00 |
| Jun 30, 2023 | 771,000.00 |
| Mar 31, 2023 | 48,000.00 |
| Dec 31, 2022 | 151,000.00 |
| Sep 30, 2022 | 130,000.00 |
| Jun 30, 2022 | 161,000.00 |
| Mar 31, 2022 | 22,000.00 |
| Dec 31, 2021 | 319,000.00 |
| Sep 30, 2021 | 208,000.00 |
| Mar 31, 2021 | 48,000.00 |
| Dec 31, 2020 | 51,000.00 |
API Access
Prothena Corp Public Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=PRTA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "PRTA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=PRTA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();